Literature DB >> 1079389

Editorial: The hemophiloid diseases and factor VIII. Clinical molecular biology.

T S Edgington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1079389      PMCID： PMC1129763     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  10 in total

Review 1.  The molecular basis of hereditary clotting disorders.

Authors:  O D Ratnoff
Journal:  Prog Hemost Thromb       Date:  1972

2.  Willebrand factor and ristocetin. II. Relationship between Willebrand factor, Willebrand antigen and factor VIII activity.

Authors:  D Meyer; C S Jenkins; M D Dreyfus; E Fressinaud; M J Larrieu
Journal:  Br J Haematol       Date:  1974-12       Impact factor: 6.998

Review 3.  Molecular immunology of factor VIII.

Authors:  T S Zimmerman; T S Edgington
Journal:  Annu Rev Med       Date:  1974       Impact factor: 13.739

4.  Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.

Authors:  H J Weiss; I W Hoyer
Journal:  Science       Date:  1973-12-14       Impact factor: 47.728

5.  Antihemophilic factor: separation of an active fragment following dissociation by salts or detergents.

Authors:  W G Owen; R H Wagner
Journal:  Thromb Diath Haemorrh       Date:  1972-07-31

6.  Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation.

Authors:  C S Jenkins; D Meyer; M D Dreyfus; M J Larrieu
Journal:  Br J Haematol       Date:  1974-12       Impact factor: 6.998

7.  Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.

Authors:  H J Weiss; J Rogers; H Brand
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

8.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

9.  Detection of carriers of classic hemophilia using an immunologic assay for antihemophilic factor (factor 8().

Authors:  T S Zimmerman; O D Ratnoff; A S Littell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

10.  Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities.

Authors:  T S Zimmerman; T S Edgington
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.